Petrichor Healthcare Capital Management LP
PETRICHOR SCION THERAPEUTICS LLC
Late investment period: first sale Jan 2022, per Form D (fund age approximates vintage)
- Vintage
- 2022
- Fund size
- $172.25M to $280.77M (Form D and SEC adviser filing)
- Stages
- Not stated
- Sectors
- Biotech, Medical devices, Healthtech
- Regions
- Global
01 · Thesis
Petrichor supports healthcare managers and businesses across company formation through late-stage and commercial growth. It supports therapeutics, medical technologies, and diagnostics, with a long-term, strategic approach for private or public companies.Inferred from the firm's website
02 · Initial check
$1.72M to $4.68M (estimated from fund size)
Estimated from Form D and SEC adviser filing
03 · Who to approach
Named on this fund's Form D
- SAMUEL HALL, Member of Issuer's Manager
- AARON KANTOFF, Member of Issuer's Manager
- TADD WESSEL, Member of Issuer's Manager
04 · Deals
No deals attributed to this fund yet.
05 · Evidence
Firm-widePetrichor supports world-class healthcare managers and businesses through a platform spanning company formation through late-stage and commercial growth.
Petrichor supports world-class healthcare managers and businesses.
https://www.petrichorcap.com/
06 · Sources
Last verified: Oct 28, 2026